Latin America Next Generation Sequencing (NGS) Market Worth $714.8 Million by 2027

The growth in this market is majorly driven by the technological advancements in sequencing procedures, surge in genome mapping programs, and increase in drug discovery platforms demanding NGS technology. Further, the growth in personalized medicine research, growing government initiatives for large-scale genomic sequencing projects, and emergence of cloud computing as a potential data management service supports the growth of the Latin America NGS market.